Guangdong Jiaying Pharmaceutical Co Ltd Financial Flexibility Index
Guangdong Jiaying Pharmaceutical Co Ltd financial flexibility index. Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Financial Flexibility Index of -0.27x as of September 2025. Free cash flow of CN¥-18.02 Million (operating CF CN¥-45.73 Million minus capex CN¥27.71 Million) represents 0% of total liabilities (CN¥65.72 Million). See Guangdong Jiaying Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Financial flexibility index of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. Historical Financial Flexibility Index trend for Guangdong Jiaying Pharmaceutical Co Ltd across 22 annual periods. Check 002198 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Guangdong Jiaying Pharmaceutical Co Ltd Financial Flexibility Index by Year (2004–2025)
Guangdong Jiaying Pharmaceutical Co Ltd financial flexibility index by year from 2004 to 2025. Year-by-year free cash flow to debt coverage for Guangdong Jiaying Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002198 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | CN¥118.93 Million | CN¥9.00 Million | CN¥131.30 Million | ▼ -26.7% |
| 2024 | 1.24x | CN¥99.55 Million | CN¥60.85 Million | CN¥80.60 Million | ▲ +0.9% |
| 2023 | 1.22x | CN¥103.51 Million | CN¥98.45 Million | CN¥84.58 Million | ▲ +384.0% |
| 2022 | 0.25x | CN¥29.89 Million | CN¥27.15 Million | CN¥118.23 Million | ▼ -42.6% |
| 2021 | 0.44x | CN¥54.14 Million | CN¥51.80 Million | CN¥122.85 Million | ▼ -49.1% |
| 2020 | 0.87x | CN¥108.55 Million | CN¥96.87 Million | CN¥125.43 Million | ▲ +424.9% |
| 2019 | 0.16x | CN¥31.78 Million | CN¥12.96 Million | CN¥192.77 Million | ▼ -75.8% |
| 2018 | 0.68x | CN¥71.05 Million | CN¥62.10 Million | CN¥104.21 Million | ▲ +76.2% |
| 2017 | 0.39x | CN¥49.07 Million | CN¥30.63 Million | CN¥126.80 Million | ▼ -32.0% |
| 2016 | 0.57x | CN¥65.11 Million | CN¥53.13 Million | CN¥114.38 Million | ▼ -11.1% |
| 2015 | 0.64x | CN¥75.73 Million | CN¥42.31 Million | CN¥118.30 Million | ▼ -45.5% |
| 2014 | 1.18x | CN¥202.10 Million | CN¥103.36 Million | CN¥171.94 Million | ▲ +356.1% |
| 2013 | 0.26x | CN¥28.18 Million | CN¥19.46 Million | CN¥109.35 Million | ▼ -21.3% |
| 2012 | 0.33x | CN¥11.85 Million | CN¥5.27 Million | CN¥36.17 Million | ▲ +2.1% |
| 2011 | 0.32x | CN¥11.56 Million | CN¥781.89K | CN¥36.04 Million | ▼ -75.4% |
| 2010 | 1.30x | CN¥55.32 Million | CN¥19.70 Million | CN¥42.40 Million | ▼ -85.2% |
| 2009 | 8.81x | CN¥104.93 Million | CN¥27.98 Million | CN¥11.91 Million | ▲ +97.1% |
| 2008 | 4.47x | CN¥39.77 Million | CN¥10.71 Million | CN¥8.89 Million | ▲ +443.5% |
| 2007 | 0.82x | CN¥27.02 Million | CN¥18.35 Million | CN¥32.85 Million | ▼ -21.7% |
| 2006 | 1.05x | CN¥39.32 Million | CN¥26.37 Million | CN¥37.42 Million | ▲ +18.9% |
| 2005 | 0.88x | CN¥23.72 Million | CN¥17.63 Million | CN¥26.84 Million | ▼ -24.4% |
| 2004 | 1.17x | CN¥26.83 Million | CN¥8.78 Million | CN¥22.95 Million | — |